Take of this statement what you will about how information is delivered and why it may not be providing the SP gains we expect. There is a saying, “Loose lips sink ships.”.
Before you slam me for it, of all the great announcements lately are any not already known by the market? We knew we were going to get $6m+ in R&D tax incentives as we had already been told.
We have been told there are 3-4 new phase 2 trials to begin with one being sponsored. So far we have had 2 of them announced, whomever those collaborations are with it was always guaranteed to be with big pharma etc except for most likely the sponsored trial.
The recent PD1-VAX announcement lacked the detail to break the current trend as it gave us nothing we didn’t know or weren’t expecting.
We have been told there will be 6-8 trials running next year. Everything is already public knowledge. We are starved of “NEW” information to create buying interest in our stock and this is why we are over sold.
If HERVaxx results aren’t mind blowing there could be more pain as only CF33 results will be able to light a fire under the SP.
Attack away
IMU Price at posting:
36.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)